| Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy MC Potilinski, GA Ortíz, JP Salica, ES López, M Fernández Acquier, ... Plos one 15 (2), e0228895, 2020 | 22 | 2020 |
| Alpha-1-antitrypsin ameliorates inflammation and neurodegeneration in the diabetic mouse retina G Ortiz, ES Lopez, JP Salica, C Potilinski, MF Acquier, E Chuluyan, ... Experimental eye research 174, 29-39, 2018 | 21 | 2018 |
| Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization ES Lopez, MM Rizzo, JO Croxatto, G Mazzolini, JE Gallo Cancer chemotherapy and pharmacology 67 (3), 723-728, 2011 | 17 | 2011 |
| Corneal neovascularization: a combined approach of bevacizumab and suramin showed increased antiangiogenic effect through downregulation of BFGF and P2X2 ES Lopez, GA Ortiz, C Potilinski, JO Croxatto, JE Gallo Current Eye Research 43 (4), 466-473, 2018 | 8 | 2018 |
| Possible neuroprotective role of P2X2 in the retina of diabetic rats JE Mancini, G Ortiz, C Potilinstki, JP Salica, ES Lopez, JO Croxatto, ... Diabetology & metabolic syndrome 10 (1), 31, 2018 | 6 | 2018 |
| Evaluation of the performance of an ophthalmic thermosensitive hydrogel containing combination of suramin and bevacizumab D Alejandra Quinteros, E Sebastian Lopez, J Lucio Silva Couto, ... Current pharmaceutical design 22 (43), 6587-6594, 2016 | 6 | 2016 |
| Effect of Bevacizumab (Avastin) and Suramin in a rabbit model of corneal neovascularization ES Lopez, JO Croxatto, A Kvanta, JE Gallo Investigative Ophthalmology & Visual Science 48 (13), 1717-1717, 2007 | 2 | 2007 |
| Alpha-1 Antitrypsin Decreases NFkB Signaling in Müller Cells in an in Vitro Diabetic Retinopathy Model. JE Gallo, MC POTILINSKI, G Ortiz, JP Salica, E López, E Chuluyán Investigative Ophthalmology & Visual Science 59 (9), 201-201, 2018 | | 2018 |
| Alpha-1 Antitrypsin Decreases Cx43 Expression Through PI3K/AKT Pathway in ARPE-19 Cells Exposed to High Glycemia MC POTILINSKI, G Ortiz, JP Salica, E López, E Chuluyán, JE Gallo Investigative Ophthalmology & Visual Science 59 (9), 196-196, 2018 | | 2018 |
| ALPHA-1-ANTITRYPSIN REDUCE LEVELS OF TUMOR NECROSIS FACTOR ALPHA BOTH IN VITRO AND IN VIVO DIABETES MODELS. JE Gallo, G Ortiz, MC POTILINSKI, JP Salica, ES Lopez, E Chuluyan Investigative Ophthalmology & Visual Science 58 (8), 5805-5805, 2017 | | 2017 |
| Suramab Strongly Inhibits Neovascularization Through Downregulation of VEGF, FGF and P2X2 receptor ES Lopez, JO Croxatto, JE Gallo Investigative Ophthalmology & Visual Science 53 (14), 2400-2400, 2012 | | 2012 |
| Poloxamer Improves the Duration of Action of Suramab to Inhibit Corneal Angiogenesis ES Lopez, J Croxatto, JE Gallo Investigative Ophthalmology & Visual Science 52 (14), 6383-6383, 2011 | | 2011 |
| Suramab Strongly Inhibits Lymphangiogenesis and Angiogenesis in the Cornea ES Lopez, OJ Croxatto, JE Gallo Investigative Ophthalmology & Visual Science 51 (13), 5694-5694, 2010 | | 2010 |
| Subconjunctival Suramab Inhibits Corneal Neovascularization ES Lopez, A Kvanta, J Croxatto, J Gallo Investigative Ophthalmology & Visual Science 50 (13), 4963-4963, 2009 | | 2009 |
| Suramab, a Pharmaceutical Compound of Bevacizumab and Suramin, Strongly Inhibits Vessels Growth in a Rabbit Model of Corneal Neovascularization ES Lopez, J Croxatto, A Kvanta, J Gallo Investigative Ophthalmology & Visual Science 49 (13), 1491-1491, 2008 | | 2008 |
